Cara Therapeutics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Cara Therapeutics (CARA) Reports Q2 Loss of $0.29/Share
August 3, 2017 4:43 PM EDTCara Therapeutics (NASDAQ: CARA) reported Q2 EPS of ($0.29), versus ($0.48) reported last year.
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
... More
